$YTENQ
YIELD10 BIOSCIENCE, INC. Stock $ytenq

$ytenq Overview Financials Valuation SEC Filings Company Website

2012 Form 10-K Financial Statement

#000104746913003558 Filed on March 28, 2013

Income Statement

Concept	2012	2011 Q4	2011 Q3
Revenue	$41.38M	$439.0K	$469.0K
YoY Change	2803.93%	299.09%	919.57%
Cost Of Revenue	$1.030M		$0.00
YoY Change
Gross Profit	$40.35M		$470.0K
YoY Change	2721.75%
Gross Profit Margin	97.51%		100.21%
Selling, General & Admin	$13.25M	$3.960M	$3.895M
YoY Change	-16.39%	3.13%	-6.39%
% of Gross Profit	32.82%		828.72%
Research & Development	$23.18M	$6.090M	$6.150M
YoY Change	-5.19%	5.73%	4.06%
% of Gross Profit	57.45%		1308.51%
Depreciation & Amortization	$1.298M	$380.0K	$360.0K
YoY Change	-13.87%	-15.56%	-7.69%
% of Gross Profit	3.22%		76.6%
Operating Expenses	$13.25M	$10.06M	$3.895M
YoY Change	-16.39%	4.79%	-6.39%
Operating Profit	$3.929M	-$9.617M	-$9.579M
YoY Change	-110.11%		-4.41%
Interest Expense	$124.0K	$10.00K	$19.00K
YoY Change	-20.51%	-50.0%	-36.67%
% of Operating Profit	3.16%
Other Income/Expense, Net	$27.00K
YoY Change	-64.47%
Pretax Income	$3.502M	-$9.600M	-$9.560M
YoY Change	-109.01%	1.37%	-4.3%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$3.630M	-$9.600M	-$9.560M
YoY Change	-109.36%	1.37%	-4.3%
Net Earnings / Revenue	8.77%	-2186.79%	-2038.38%
Basic Earnings Per Share	$0.11	-$0.28	-$0.28
Diluted Earnings Per Share	$0.11	-$0.28	-$0.28
COMMON SHARES
Basic Shares Outstanding	34.22M shares	34.11M shares	34.08M shares
Diluted Shares Outstanding	34.28M shares		34.08M shares

Balance Sheet

Concept	2012	2011 Q4	2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$43.80M	$76.90M	$72.70M
YoY Change	-43.04%	24.84%	4.01%
Cash & Equivalents	$14.60M	$21.28M	$17.39M
Short-Term Investments	$29.20M	$55.60M	$55.30M
Other Short-Term Assets	$700.0K	$800.0K	$500.0K
YoY Change	-12.5%	0.0%	25.0%
Inventory	$3.200M	$0.00
Prepaid Expenses
Receivables	$1.300M	$146.0K	$800.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$49.00M	$78.44M	$73.93M
YoY Change	-37.5%	24.0%	4.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.400M	$2.276M	$2.300M
YoY Change	-39.13%	-18.01%	-25.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.500M	$1.500M	$14.50M
YoY Change	66.67%
Other Assets	$700.0K	$72.00K	$700.0K
YoY Change	0.0%	-38.46%	0.0%
Total Long-Term Assets	$4.500M	$4.473M	$17.48M
YoY Change	0.0%	27.25%	359.89%
TOTAL ASSETS
Total Short-Term Assets	$49.00M	$78.44M	$73.93M
Total Long-Term Assets	$4.500M	$4.473M	$17.48M
Total Assets	$53.50M	$82.91M	$91.41M
YoY Change	-35.46%	24.17%	22.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.200M	$512.0K	$500.0K
YoY Change	140.0%	114.23%
Accrued Expenses	$3.500M	$3.574M	$3.600M
YoY Change	-2.78%	-12.51%	-18.18%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.000M	$7.165M	$6.957M
YoY Change	-16.67%	12.04%	-2.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$200.0K	$119.0K	$36.60M
YoY Change	-99.45%	11.21%	2.23%
Total Long-Term Liabilities	$200.0K	$119.0K	$36.60M
YoY Change	-99.45%	11.21%	2.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.000M	$7.165M	$6.957M
Total Long-Term Liabilities	$200.0K	$119.0K	$36.60M
Total Liabilities	$6.200M	$43.45M	$43.54M
YoY Change	-85.71%	0.82%	1.72%
SHAREHOLDERS EQUITY
Retained Earnings		-$245.7M
YoY Change		18.75%
Common Stock		$285.1M
YoY Change		23.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$47.30M	$39.46M	$47.90M
YoY Change
Total Liabilities & Shareholders Equity	$53.50M	$82.91M	$91.41M
YoY Change	-35.46%	24.17%	22.53%

Cashflow Statement

Concept	2012	2011 Q4	2011 Q3
OPERATING ACTIVITIES
Net Income	$3.630M	-$9.600M	-$9.560M
YoY Change	-109.36%	1.37%	-4.3%
Depreciation, Depletion And Amortization	$1.298M	$380.0K	$360.0K
YoY Change	-13.87%	-15.56%	-7.69%
Cash From Operating Activities	-$31.74M	-$8.610M	-$7.820M
YoY Change	0.02%	6.56%	10.3%
INVESTING ACTIVITIES
Capital Expenditures	$392.0K	-$270.0K	-$140.0K
YoY Change	-56.2%	3.85%	-53.33%
Acquisitions
YoY Change
Other Investing Activities	$25.41M	$12.77M	$5.580M
YoY Change	-417.23%	99.53%	-25.5%
Cash From Investing Activities	$25.02M	$12.49M	$5.450M
YoY Change	-380.79%	103.09%	-24.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.00K	10.00K	-10.00K
YoY Change	-99.96%	-50.0%	-105.88%
NET CHANGE
Cash From Operating Activities	-$31.74M	-8.610M	-7.820M
Cash From Investing Activities	$25.02M	12.49M	5.450M
Cash From Financing Activities	20.00K	10.00K	-10.00K
Net Change In Cash	-$6.718M	3.890M	-2.380M
YoY Change	-176.6%	-303.66%	-981.48%
FREE CASH FLOW
Cash From Operating Activities	-$31.74M	-$8.610M	-$7.820M
Capital Expenditures	$392.0K	-$270.0K	-$140.0K
Free Cash Flow	-$32.13M	-$8.340M	-$7.680M
YoY Change	-1.52%	6.65%	13.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012	mblx	Revenue Recognition Period For Which Limited Right Of Return Provided To Customers RevenueRecognitionPeriodForWhichLimitedRightOfReturnProvidedToCustomers	P60D
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5583128	shares
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3862771	shares
CY2010	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3250165	shares
CY2011Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7130000	shares
CY2011Q2	mblx	Common Stock Issue Price Per Share CommonStockIssuePricePerShare	7.25
CY2011Q2	mblx	Common Stock Issuances Underwriting Discounts Commissions And Offering Costs CommonStockIssuancesUnderwritingDiscountsCommissionsAndOfferingCosts	2360000	USD
CY2011Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49333000	USD
CY2012Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4086	shares
CY2012Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	3.30
CY2012	mblx	Class Of Warrant Or Right Expiration Term ClassOfWarrantOrRightExpirationTerm	P10Y
CY2009Q3	mblx	Class Of Warrant Or Right Dividend Distribution Number Of Units Per Common Stock Share ClassOfWarrantOrRightDividendDistributionNumberOfUnitsPerCommonStockShare	1	shares
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-242032000	USD
CY2011Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	304000	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	823000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	78439000	USD
CY2011Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	622000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2276000	USD
CY2011Q4	us-gaap	Long Term Investments LongTermInvestments	1503000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	72000	USD
CY2011Q4	us-gaap	Assets Assets	82912000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14572000	USD
CY2012Q4	us-gaap	Short Term Investments ShortTermInvestments	29201000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	839000	USD
CY2012Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	75000	USD
CY2012Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	372000	USD
CY2012	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y4M17D
CY2012Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	6.68
CY2012Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2954377	shares
CY2012Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	9.41
CY2012	dei	Entity Registrant Name EntityRegistrantName	METABOLIX, INC.
CY2012	dei	Entity Central Index Key EntityCentralIndexKey	0001121702
CY2012	dei	Document Type DocumentType	10-K
CY2012	dei	Document Period End Date DocumentPeriodEndDate	2012-12-31
CY2012	dei	Amendment Flag AmendmentFlag	false
CY2012	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2012	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2012	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2012	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2012	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34365227	shares
CY2012Q2	dei	Entity Public Float EntityPublicFloat	43387737.	USD
CY2012	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21277000	USD
CY2011Q4	us-gaap	Short Term Investments ShortTermInvestments	55578000	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	146000	USD
CY2011Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	311000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	692000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	48955000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	594000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1358000	USD
CY2012Q4	us-gaap	Long Term Investments LongTermInvestments	2508000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	95000	USD
CY2012Q4	us-gaap	Assets Assets	53510000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	289050000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	512000	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3574000	USD
CY2011Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	165000	USD
CY2011Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2914000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7165000	USD
CY2011Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	221000	USD
CY2011Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	35944000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	119000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	43449000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1233000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3519000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	165000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1067000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5984000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	55000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	131000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	6170000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	341000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	284796000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-245662000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	39463000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	82912000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	343000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	47340000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53510000	USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34115798	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34115798	shares
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34306570	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34306570	shares
CY2011	us-gaap	Revenue From Grants RevenueFromGrants	918000	USD
CY2011	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	447000	USD
CY2011	us-gaap	Licenses Revenue LicensesRevenue	60000	USD
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	1425000	USD
CY2010	us-gaap	Revenue From Grants RevenueFromGrants	64000	USD
CY2010	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	122000	USD
CY2010	us-gaap	Licenses Revenue LicensesRevenue	50000	USD
CY2010	mblx	Research And Development Revenue ResearchAndDevelopmentRevenue	212000	USD
CY2010	us-gaap	Sales Revenue Net SalesRevenueNet	448000	USD
CY2012	us-gaap	Revenue From Grants RevenueFromGrants	1971000	USD
CY2012	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	152000	USD
CY2012	us-gaap	Licenses Revenue LicensesRevenue	97000	USD
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	42316000	USD
CY2011	mblx	Cost Of Revenue Research And Development Expenses CostOfRevenueResearchAndDevelopmentExpenses	24445000	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15841000	USD
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	40286000	USD
CY2012	mblx	Cost Of Revenue Research And Development Expenses CostOfRevenueResearchAndDevelopmentExpenses	23177000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14110000	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	38713000	USD
CY2010	mblx	Cost Of Revenue Research And Development Expenses CostOfRevenueResearchAndDevelopmentExpenses	23673000	USD
CY2010	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15714000	USD
CY2010	us-gaap	Costs And Expenses CostsAndExpenses	39387000	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-38939000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	3603000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-38861000	USD
CY2011	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	76000	USD
CY2010	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	136000	USD
CY2012	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	27000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38785000	USD
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38803000	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3630000	USD
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-28000	USD
CY2010	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-9000	USD
CY2010	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-37000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3000	USD
CY2011	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-17000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	20000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1507000	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1647000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	4633000	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	4696000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1298000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	3807000	USD
CY2011	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	146000	USD
CY2010	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-19000	USD
CY2011	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	296000	USD
CY2010	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	5000	USD
CY2011	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	71000	USD
CY2010	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	15000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-68000	USD
CY2010	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	104000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	273000	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-387000	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-623000	USD
CY2010	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	329000	USD
CY2011	mblx	Increase Decrease In Deferred Rent And Other Long Term Liabilities IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities	-153000	USD
CY2010	mblx	Increase Decrease In Deferred Rent And Other Long Term Liabilities IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities	-156000	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1333000	USD
CY2010	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	341000	USD
CY2012	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	693000	USD
CY2012	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	68000	USD
CY2012	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-236000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-108000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	721000	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-34000	USD
CY2012	mblx	Increase Decrease In Deferred Rent And Other Long Term Liabilities IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities	-154000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-37791000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31731000	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31995000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31736000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	392000	USD
CY2012	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	58933000	USD
CY2012	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	84303000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	25018000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	895000	USD
CY2011	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	107477000	USD
CY2011	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	99464000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-8908000	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	906000	USD
CY2010	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	29000	USD
CY2010	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	83814000	USD
CY2010	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	116126000	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	31377000	USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12000	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2339000	USD
CY2010	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-9000	USD
CY2010	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	1712000	USD
CY2012	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-6000	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49333000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	49407000	USD
CY2011	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-17000	USD
CY2011	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	8751000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	19000	USD
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-6000	USD
CY2012	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-6705000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12526000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10814000	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	49333000	USD
CY2010	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-9000	USD
CY2011	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-17000	USD
CY2012	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-6000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2360000	USD
CY2010	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2339000	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	74000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4696000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4633000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3807000	USD
CY2010	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	437000	USD
CY2011	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	529000	USD
CY2012	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	430000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	31696000	USD
CY2011Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	57066000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	13000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	18000	USD
CY2011Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	3000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	31709000	USD
CY2011Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	57081000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8400000	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5924000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7042000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8200000	USD
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1740000	USD
CY2011Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	185000	USD
CY2011Q4	mblx	Accrued Intellectual Property Current AccruedIntellectualPropertyCurrent	240000	USD
CY2011Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1409000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2379000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	301000	USD
CY2012Q4	mblx	Accrued Intellectual Property Current AccruedIntellectualPropertyCurrent	105000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	734000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1814000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1808000	USD
CY2010	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1674000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1744000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	550000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2294000	USD
CY2012	us-gaap	Use Of Estimates UseOfEstimates	<div style='font-size:10.0pt;FONT-FAMILY: Times New Roman;'> <p style="FONT-FAMILY: times"><font size="2"><b>Use of Estimates</b></font></p> <p style="FONT-FAMILY: times"><font size="2">        The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></p></div>
CY2012	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style='font-size:10.0pt;FONT-FAMILY: Times New Roman;'> <p style="FONT-FAMILY: times"><font size="2"><b>Concentration of Credit Risk</b></font></p> <p style="FONT-FAMILY: times"><font size="2">        Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash and cash equivalents and short-term investments. The Company primarily invests its excess cash and cash equivalents in money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments are acquired in accordance with the Company's investment policy which establishes a concentration limit per issuer.</font></p> <p style="FONT-FAMILY: times"><font size="2">        The Company provides credit to customers in the normal course of business. The Company performs ongoing credit evaluations of its customers' financial condition and limits the amount of credit extended when deemed necessary. At December 31, 2012, the Company's accounts and unbilled receivables include $561 or 46% from U.S. and Canadian government grants and $535 or 44% from customer product sales. At December 31, 2012, one customer represented 41% of accounts receivable due from product sales.</font></p></div>
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	7024000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	6762000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1541000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1261000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	72016000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	61269000	USD
CY2012Q4	mblx	Deferred Tax Assets Capitalized Research And Development Expenses DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses	2763000	USD
CY2011Q4	mblx	Deferred Tax Assets Capitalized Research And Development Expenses DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses	3606000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	90577000	USD
CY2012	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.045	pure
CY2012	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	179336	shares
CY2011Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	94672000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	90577000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94672000	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.078	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.050	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.041	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.196	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.024	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.015	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.105	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.024	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.020	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.031	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.014	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.065	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1.130	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.398	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.288	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2010	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2012Q4	mblx	Operating Loss Carryforwards Attributable To Deduction Related To Exercise Of Stock Options OperatingLossCarryforwardsAttributableToDeductionRelatedToExerciseOfStockOptions	19213000	USD
CY2011	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	68558	shares
CY2010	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	35151	shares
CY2011Q4	mblx	Government Grants Multi Year Agreement Amount GovernmentGrantsMultiYearAgreementAmount	6000000	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	39322000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	923000	USD
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	674000	USD
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	1397000	USD
CY2011Q1	us-gaap	Sales Revenue Net SalesRevenueNet	326000	USD
CY2011Q2	us-gaap	Sales Revenue Net SalesRevenueNet	191000	USD
CY2011Q3	us-gaap	Sales Revenue Net SalesRevenueNet	469000	USD
CY2011Q4	us-gaap	Sales Revenue Net SalesRevenueNet	439000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	28823000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7957000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7743000	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-9520000	USD
CY2011Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9660000	USD
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-10005000	USD
CY2011Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9579000	USD
CY2011Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-9617000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7948000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7745000	USD
CY2012Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9517000	USD
CY2011Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9640000	USD
CY2011Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9982000	USD
CY2011Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9560000	USD
CY2011Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9603000	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	55044000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	23676000	USD
CY2010	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2339000	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	74000	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19000	USD
CY2012	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	item
CY2012Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	5579042	shares
CY2012	us-gaap	Defined Contribution Plan Maximum Annual Contribution Per Employee Percent DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent	0.60	pure
CY2011	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	529000	USD
CY2010	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	443000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	408000	USD
CY2011	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	515000	USD
CY2009Q3	mblx	Class Of Warrant Or Right Condition On Exercise Of Rights Percentage Of Common Stock Acquired Minimum ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredMinimum	0.15	pure
CY2009Q3	mblx	Class Of Warrant Or Right Condition On Exercise Of Rights Percentage Of Common Stock Acquired Through Tender Or Exchange Offer Minimum ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTenderOrExchangeOfferMinimum	0.15	pure
CY2011	mblx	Charge For Company Common Stock Match ChargeForCompanyCommonStockMatch	529000	USD
CY2010	mblx	Charge For Company Common Stock Match ChargeForCompanyCommonStockMatch	443000	USD
CY2012	mblx	Charge For Company Common Stock Match ChargeForCompanyCommonStockMatch	408000	USD
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34217298	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31257376	shares
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26773755	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	62481	shares
CY2012	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	62481	shares
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34279779	shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31257376	shares
CY2010	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26773755	shares
CY2012	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	1578000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	640000	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2000	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2562000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	3204000	USD
CY2012	us-gaap	Restructuring And Related Cost Cost Incurred To Date RestructuringAndRelatedCostCostIncurredToDate	920000	USD
CY2011Q4	us-gaap	Restructuring Reserve RestructuringReserve	859000	USD
CY2012	us-gaap	Restructuring Reserve Accrual Adjustment RestructuringReserveAccrualAdjustment	61000	USD
CY2012	us-gaap	Restructuring Reserve Settled With Cash RestructuringReserveSettledWithCash	920000	USD
CY2012	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1211000	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1426000	USD
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2010	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.45
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2010	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.45
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3204000	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-28000	USD
CY2012	mblx	Revenue From Termination Of Collaboration With Subsidiary RevenueFromTerminationOfCollaborationWithSubsidiary	38885000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3621000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38782000	USD
CY2010	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38840000	USD
CY2012	mblx	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses And Credits EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAndCredits	0.492	pure
CY2011	mblx	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses And Credits EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAndCredits	-0.016	pure
CY2010	mblx	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses And Credits EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAndCredits	-0.003	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.098	pure
CY2010Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.010	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.030	pure
CY2012	mblx	Maximum Period To Audit For Loss MaximumPeriodToAuditForLoss	P3Y
CY2012	mblx	Minimum Period For Which Cash Cash Equivalents Investments And Cash From Expected Product Sales Is Sufficient To Meet Projected Operating Requirements MinimumPeriodForWhichCashCashEquivalentsInvestmentsAndCashFromExpectedProductSalesIsSufficientToMeetProjectedOperatingRequirements	P12M
CY2012Q4	us-gaap	Deferred Revenue DeferredRevenue	786000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.84
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2011Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2011Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2011Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2011Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2012	us-gaap	Segment Reporting Information Revenue SegmentReportingInformationRevenue	42316000	USD
CY2011	us-gaap	Segment Reporting Information Revenue SegmentReportingInformationRevenue	1425000	USD
CY2010	us-gaap	Segment Reporting Information Revenue SegmentReportingInformationRevenue	448000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2776000	USD
CY2012	mblx	Earnings Per Share Basic And Diluted Adjustment EarningsPerShareBasicAndDilutedAdjustment	0
CY2012	mblx	Collaborative Arrangement Settlement Agreement Third Party Creditor Trade Obligations Paid CollaborativeArrangementSettlementAgreementThirdPartyCreditorTradeObligationsPaid	0	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2010Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2012	mblx	Restricted Cash Held In Connection With Lease Agreements Number RestrictedCashHeldInConnectionWithLeaseAgreementsNumber	2	item

Files In Submission

Name	View Source	Status
0001047469-13-003558-index-headers.html	Edgar Link	pending
0001047469-13-003558-index.html	Edgar Link	pending
0001047469-13-003558.txt	Edgar Link	pending
0001047469-13-003558-xbrl.zip	Edgar Link	pending
a2213970z10-k.htm	Edgar Link	pending
a2213970zex-10_27.htm	Edgar Link	pending
a2213970zex-21_1.htm	Edgar Link	pending
a2213970zex-23_1.htm	Edgar Link	pending
a2213970zex-31_1.htm	Edgar Link	pending
a2213970zex-31_2.htm	Edgar Link	pending
a2213970zex-32_1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g579645.jpg	Edgar Link	pending
mblx-20121231.xml	Edgar Link	completed
mblx-20121231.xsd	Edgar Link	pending
mblx-20121231_cal.xml	Edgar Link	unprocessable
mblx-20121231_def.xml	Edgar Link	unprocessable
mblx-20121231_lab.xml	Edgar Link	unprocessable
mblx-20121231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$YTENQ
YIELD10 BIOSCIENCE, INC. Stock $ytenq

2012 Form 10-K Financial Statement

#000104746913003558 Filed on March 28, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YTENQ YIELD10 BIOSCIENCE, INC. Stock $ytenq

2012 Form 10-K Financial Statement

#000104746913003558 Filed on March 28, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YTENQ
YIELD10 BIOSCIENCE, INC. Stock $ytenq